Dosimetric and radiobiological comparison of prostate VMAT plans optimized using the photon and progressive resolution algorithm

核医学 剂量体积直方图 前列腺 医学 剂量学 放射治疗计划 放射治疗 算法 数学 放射科 癌症 内科学
作者
J Chow,Runqing Jiang,Lu Xu
出处
期刊:Medical Dosimetry [Elsevier BV]
卷期号:45 (1): 14-18 被引量:5
标识
DOI:10.1016/j.meddos.2019.04.004
摘要

This study compared the dosimetric and radiobiological parameters of prostate volumetric modulated arc therapy (VMAT) plans using different prescriptions optimized by the photon optimization (PO) and progressive resolution optimization (PRO) algorithm. A total of 20 prostate patients were selected retrospectively and divided into 2 groups of VMAT plans using prescriptions of 60 Gy/20 fx and 79 Gy/38 fx. Inverse treatment planning optimized by the PO and PRO algorithm based on the dual-arc technique was carried out by the Eclipse treatment planning system. The maximum dose, minimum dose, mean dose, dose-volume points, and dose-volume indices of the targets and organs at risk (OAR) were calculated from the plans. In addition, radiobiological parameters such as tumor control probability (TCP), normal tissue complication probability (NTCP), and equivalent uniform dose (EUD) of the targets and OAR were determined based on their dose-volume histograms (DVHs). A paired Student's t-test was carried out to compare the difference between mean dose-volume points, radiobiological parameters, and dose-volume indices. Two-tailed p < 0.05 was defined as having statistical difference. For prostate VMAT plans optimized by the PO algorithm, equal or slightly larger mean dose and TCP of the PTV (1% for 60 Gy/20 fx and 0.2% for 78 Gy/39 fx) were found by comparing to the PRO. These were followed by finding the slightly larger conformity index (CI; 0.927 vs 0.895 and 0.910 vs 0.904), larger or equal homogeneity index (HI; 0.054 vs 0.052 and 0.058 vs 0.058), and smaller gradient index (GI; 1.366 vs 2.288 and 1.585 vs 1.742) of the PTV using plans optimized by the PO vs PRO using prescriptions of 60 Gy/20 fx and 78 Gy/39 fx. For the OAR, we found that the mean doses, NTCPs, and EUDs of the rectum, bladder, and femur were slightly larger for plans optimized by the PO algorithm compared to the PRO, though both optimization algorithms satisfied all the dose-volume criteria and objectives in the inverse planning. Both the PO and PRO algorithm can generate prostate VMAT plans fulfilling the required dose-volume criteria. It is concluded that plans optimized by the PO algorithm can produce prostate plan with very similar quality compared to PRO.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
molihuakai应助Zeno采纳,获得10
刚刚
有点意思发布了新的文献求助10
刚刚
雁阵完成签到,获得积分10
刚刚
健壮的芷容完成签到,获得积分10
刚刚
渤大彭于晏完成签到,获得积分10
刚刚
冲冲冲完成签到,获得积分20
1秒前
隐形的西牛完成签到,获得积分10
1秒前
闫123完成签到,获得积分10
2秒前
慕1完成签到,获得积分10
2秒前
我想睡觉发布了新的文献求助10
3秒前
ysf完成签到,获得积分10
3秒前
星星完成签到,获得积分10
3秒前
Cookies完成签到,获得积分10
3秒前
朻安完成签到,获得积分10
3秒前
儒雅的书白完成签到,获得积分10
4秒前
4秒前
不想科研完成签到,获得积分10
4秒前
鸣鸣完成签到,获得积分10
5秒前
xuejingling完成签到,获得积分10
5秒前
隐形的书雁完成签到 ,获得积分10
5秒前
lxd621478完成签到,获得积分10
6秒前
沙力VAN完成签到,获得积分10
6秒前
羊羊羊完成签到,获得积分10
6秒前
Morning晨完成签到,获得积分10
7秒前
7秒前
不做第一只做唯一完成签到,获得积分0
7秒前
李一诺完成签到 ,获得积分10
8秒前
Chouvikin完成签到,获得积分10
8秒前
LinYX完成签到,获得积分10
8秒前
Rohee完成签到 ,获得积分20
8秒前
ju00完成签到,获得积分10
9秒前
lxd621478发布了新的文献求助10
9秒前
科目三应助joleisalau采纳,获得10
9秒前
胡明轩完成签到 ,获得积分10
10秒前
老实妙之完成签到,获得积分10
10秒前
lcsw发布了新的文献求助10
10秒前
荀煜祺完成签到,获得积分10
10秒前
恶恶么v完成签到,获得积分10
10秒前
小石头完成签到,获得积分10
10秒前
京城世界完成签到,获得积分10
11秒前
高分求助中
Adhesion Science: Principles & Practice 1234
Signals, Systems, and Signal Processing 610
Introduction to Cosmetic Formulation and Technology, 2nd Edition 400
Petrology and Plate Tectonics,2025 400
Burger's Medicinal Chemistry and Drug Discovery 400
Programming for Chemical Engineers Using C, C++, and MATLAB 320
Birth of Twins After Genome Editing for HIV Resistance 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6689217
求助须知:如何正确求助?哪些是违规求助? 8432930
关于积分的说明 18016314
捐赠科研通 5915025
什么是DOI,文献DOI怎么找? 2984190
邀请新用户注册赠送积分活动 1960203
关于科研通互助平台的介绍 1898297